BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9654162)

  • 1. Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia?
    Chakrabarti S; Varma S; Singh S; Kumari S
    Eur J Haematol; 1998 May; 60(5):313-4. PubMed ID: 9654162
    [No Abstract]   [Full Text] [Related]  

  • 2. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
    Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet Count of Zero: A Curious Case of Thrombocytopenia.
    Twohig P; Rivington J
    Am J Med; 2017 Nov; 130(11):e495-e496. PubMed ID: 28602877
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of antifibrinolytic drugs in orthotopic liver transplantation.
    Dalmau A; Sabaté A; Acosta F; Garcia-Huete L; Koo M; Reche M; Rafecas A; Figueras J; Jaurrieta E
    Transplant Proc; 1999 Sep; 31(6):2361-2. PubMed ID: 10500617
    [No Abstract]   [Full Text] [Related]  

  • 5. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy.
    Gunaydin B; Ozkose Z; Pezek S
    J Anesth; 2007; 21(1):106-7. PubMed ID: 17285428
    [No Abstract]   [Full Text] [Related]  

  • 7. Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage.
    Kalmadi S; Tiu R; Lowe C; Jin T; Kalaycio M
    Cancer; 2006 Jul; 107(1):136-40. PubMed ID: 16708357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective Study of 122 Dogs That Were Treated with the Antifibrinolytic Drug Aminocaproic Acid: 2010-2012.
    Davis M; Bracker K
    J Am Anim Hosp Assoc; 2016; 52(3):144-8. PubMed ID: 27008326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid versus aminocaproic acid for blood management after total knee and total hip arthroplasty: A systematic review and meta-analysis.
    Liu Q; Geng P; Shi L; Wang Q; Wang P
    Int J Surg; 2018 Jun; 54(Pt A):105-112. PubMed ID: 29723672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series.
    Marshall A; Li A; Drucker A; Dzik W
    Hematol Oncol; 2016 Sep; 34(3):147-53. PubMed ID: 25641349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
    Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
    J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood loss and transfusion requirements with epsilon-aminocaproic acid use during cranial vault reconstruction surgery.
    Thompson ME; Saadeh C; Watkins P; Nagy L; Demke J
    J Clin Anesth; 2017 Feb; 36():153-157. PubMed ID: 28183556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty.
    Churchill JL; Puca KE; Meyer ES; Carleton MC; Truchan SL; Anderson MJ
    J Arthroplasty; 2016 Dec; 31(12):2795-2799.e1. PubMed ID: 27286909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis.
    Munoz JJ; Birkmeyer NJ; Birkmeyer JD; O'Connor GT; Dacey LJ
    Circulation; 1999 Jan 5-12; 99(1):81-9. PubMed ID: 9884383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of epsilon-aminocaproic acid to reduce bleeding.
    Lemmer JH
    J Thorac Cardiovasc Surg; 1997 Jun; 113(6):1125-7. PubMed ID: 9202701
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemophilia and EACA.
    Radivoyevitch MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Aug; 82(2):118. PubMed ID: 8863298
    [No Abstract]   [Full Text] [Related]  

  • 17. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation.
    Dalmau A; Sabaté A; Acosta F; Garcia-Huete L; Koo M; Sansano T; Rafecas A; Figueras J; Jaurrieta E; Parrilla P
    Anesth Analg; 2000 Jul; 91(1):29-34. PubMed ID: 10866882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrinolytic therapy.
    Schisano G; Nina P
    J Neurosurg; 1997 Sep; 87(3):486-7. PubMed ID: 9285628
    [No Abstract]   [Full Text] [Related]  

  • 19. Are antifibrinolytic agents effective in the treatment of aneurysmal subarachnoid hemorrhage?
    Eastin TR; Snipes CD; Seupaul RA
    Ann Emerg Med; 2014 Dec; 64(6):658-9. PubMed ID: 24954579
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
    Ozelo MC; Svirin P; Larina L
    Ann Hematol; 2005 Nov; 84(12):816-22. PubMed ID: 16044315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.